tirzepatide mash phase 3 Shows Superior Weight Loss Over Semaglutide in Trial Phase 3 randomized controlled clinical

Longer-term prospective studies or randomized clinical trials with psychiatric endpoints are warranted to validate this association and to explore potential biological mechanisms in greater detail

Ozempic for Weight Loss While multiple studies show Mounjaro is more effective than Ozempic for weight loss, the FDA has not approved it for that use

Gastrointestinal Sensitivity: Some experts suggest monitoring infants for GLP-1-like side effects

In the first nine months of 2025, Mounjaro and Zepbound generated combined sales of $24.8 billion for the company (accounting for 54% of Eli Lillys revenue)

August 2, 2024: Blood Clots, DVT, Pulmonary Embolisms Possibly Linked to GLP-1 Drugs A data analysis published in the Endocrine Journal has medical professionals taking a new look at how semaglutide drugs might cause a specific type of blood clot

You may not notice changes on the scale until a few weeks into your protocol